Intratumoral recruitment of Th17 cells was proposed to rely on various chemokines depending on the tumor context, such as CCL20 [58], CCL17, CCL22 [56], MIF [57], RANTES, MCP1 [55], or CCL4 produced by immature myeloid cells [59]. The gene discussed is CCL20; the disease is neoplasm.